Laboratory Automation Systems Market: By Product (Laboratory Automation Software, Components and Laboratory Automation Systems), By Application (Forensic, Life Sciences & Biotechnology, Clinical Diagnostics, and Others), By End-User (Academic Institutes and Research Organizations, Clinical Laboratories, Others) Regional Analysis & Forecast - 2026
- OI-140 |
- Published date: Jun, 2019 |
- Medical Devices |
- 120 Pages
Introduction
Laboratories can handle the movement of specimens across disciplines and generate results quickly with the help of fully automated laboratory automation systems. In research and pharmaceutical industries, the ability to move liquids in laboratories in a predefined volume is essential. The laboratory automated systems use the contact or non-contact methodologies to offer a range of features to help control liquid dispensing
Market Overview
The Global Laboratory Automation Systems market was valued at $ 4.3 bn in 2018 and is forecasted to grow at a CAGR of 6.8% between 2018 and 2026, resulting in 2026 global sales of $ XX. The market is driven by owing rising funding from government and corporate sector and cost-effectiveness. However, the lack of planning for technology is expected to restrain the market growth. Moreover, the shortage of highly skilled laboratory personnel is providing opportunities for the market
Laboratory Automation System depending on the product, Laboratory Automation Software segment is expected to account for the largest share of the Laboratory Automation System market due to Software offers standardized, real-time data-driven decision making to help reduce errors in data handling. Achieve new levels of power, performance, and simplicity with this automated software
Key Developments
- February 2017 - Thermo Fisher Scientific Inc. acquired Finesse Solutions Inc., a leader in the development of scalable control automation systems and software for bioproduction
Segmentation
The Global Laboratory Automation Systems market is segmented on the basis of Product, Application, End-User, and Region
Based on the Product: Laboratory Automation Software, Components and Laboratory Automation Systems
Based on the Application: Forensic, Life Sciences & Biotechnology, Clinical Diagnostics, and Other Applications
Based on the End User: Academic Institutes and Research Organizations, Clinical Laboratories, Commercial Biotechnology, and Pharmaceutical & Bio-Pharmaceutical Industries and CROs
Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia-Pacific held the largest share of the market due to the demand for standardization in the biopharmaceutical and biotechnology industry. In addition, many players have invested in the development of new drugs
The key players of the Global Laboratory Automation System market include Thermo Fisher Scientific, Inc, Tecan Group Ltd., SCINOMIX, QIAGEN N.V., PerkinElmer, Inc, LabVantage Solutions, Inc, Hudson Robotics, Inc, Hamilton Company, Gilson, Inc., F. Hoffmann-La Roche AG, DASSAULT SYSTEMES, Danaher Corporation, BioTek Instruments, Inc., Biosero Inc, bioMerieux SA, Becton Dickinson and Company, Apricot Designs, Inc, Agilent Technologies, Inc. and Abbott Laboratories
Report Description: The report covers in-depth analysis of Global Laboratory Automation Systems Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by Type (Manual Laboratory Automation System Systems, Automated Laboratory Automation System Systems, and Electronic Laboratory Automation System Systems). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations
The report includes in-depth company profiles of key players in the Global Laboratory Automation Systems Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants
Scope:
- Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Laboratory Automation Systems Market
- Provides key information on players involved on the Global Laboratory Automation Systems Market
- Provides a complete overview of market segments and the regional outlook of the Global Laboratory Automation Systems Market
- Provides in-depth coverage of key news related to Global Laboratory Automation Systems Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
